Izumerogant (IMU-935) is a drug which acts as both a selective antagonist of the receptor RAR-related orphan receptor gamma (RORγ), and also an inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH). It has antiinflammatory and broad-spectrum antiviral effects, and is also of interest in the treatment of cancer.
References